On Tuesday 14 February, the FDA warned against using Avastin 25 mg/ml.
FDA: Avastin (bevacizumab): Counterfeit Product - FDA Issues Letters to 19 Medical Practices
The counterfeit Avastin is not distributed in Denmark.
Anne-Marie Vangsted
Director of Division
Medicines Control Division
+45 4488 9315
amv@dkma.dk